Pharmacoeconomic analysis of the use of actovegin in patients with post-stroke cognitive impairment in the health care system of the Russian Federation

Post-stroke cognitive impairment (PSCI) is often characterized by a complex prognosis of neurorehabilitation, insufficient restoration of the functional status of patients, and a high risk of recurrent strokes and disability, which determines considerable health care costs. Objective: to carry out a...

Celý popis

Podrobná bibliografie

Hlavní autoři:	V. V. Ryazhenov, S. G. Gorokhova, A. V. Knyazev
Médium:	Artigo
Jazyk:	Russo
Vydáno:	IMA-PRESS LLC 2018-11-01
Edice:	Неврология, нейропсихиатрия, психосоматика
Témata:	ischemic stroke cognitive impairment dementia actovegin pharmacoeconomic analysis, cost-effectiveness indicator budget impact analysis
On-line přístup:	https://nnp.ima-press.net/nnp/article/view/951
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!